PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
-4.35%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$264M
AUM Growth
-$63.1M
(-19%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-12.06%
Top 10 Holdings %
Top 10 Hldgs %
53.84%
Holding
118
New
20
Increased
17
Reduced
12
Closed
28
Top Buys
| 1 |
Grifois
GRFS
|
$9.94M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$6.11M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$5.55M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.14M |
| 5 |
Establishment Labs
ESTA
|
$4.83M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$10.1M |
| 2 |
Danaher
DHR
|
$7.15M |
| 3 |
ARQL
Arqule Inc
ARQL
|
$6.98M |
| 4 |
Guardant Health
GH
|
$6.04M |
| 5 |
Zimmer Biomet
ZBH
|
$5.84M |
Sector Composition
| 1 | Healthcare | 87.98% |
| 2 | Industrials | 2.56% |
| 3 | Consumer Staples | 1.56% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Apyx Medical
APYX
$74.1M
| $2.88M | 0.49% |
425,872
+28,600
| +7% | +$194K |
|
27
Castle Biosciences
CSTL
$683M
| $2.38M | 0.41% |
+131,718
| New | +$2.38M |
|
|
OTIC
28
DELISTED
Otonomy, Inc.
OTIC
| $2.37M | 0.41% |
993,463
| – | – |
|
29
Tandem Diabetes Care
TNDM
$850M
| $2.36M | 0.4% |
40,000
+30,000
| +300% | +$1.77M |
|
30
Standard BioTools
LAB
$497M
| $2.32M | 0.4% |
500,000
+260,000
| +108% | +$1.2M |
|
|
BDSI
31
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.17M | 0.37% |
515,111
-110,124
| -18% | -$464K |
|
32
Cytokinetics
CYTK
$6.34B
| $2.14M | 0.37% |
+188,096
| New | +$2.14M |
|
|
VRAY
33
DELISTED
ViewRay, Inc.
VRAY
| $2.13M | 0.36% |
734,994
-115,006
| -14% | -$333K |
|
|
ACHN
34
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.04M | 0.35% |
+566,600
| New | +$2.04M |
|
35
TG Therapeutics
TGTX
$5.11B
| $1.99M | 0.34% |
354,719
| – | – |
|
|
MSON
36
DELISTED
Misonix Inc
MSON
| $1.88M | 0.32% |
93,645
+600
| +0.6% | +$12.1K |
|
|
BHVN
37
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $1.67M | 0.29% |
+40,000
| New | +$1.67M |
|
|
DCPH
38
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.39M | 0.24% |
+41,000
| New | +$1.39M |
|
39
Arvinas
ARVN
$575M
| $1.38M | 0.24% |
+64,209
| New | +$1.38M |
|
|
STML
40
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.38M | 0.24% |
132,422
-21,176
| -14% | -$221K |
|
41
KALA BIO
KALA
$102M
| $1.27M | 0.22% |
6,663
+685
| +11% | +$130K |
|
42
Zymeworks
ZYME
$1.14B
| $1.24M | 0.21% |
+50,000
| New | +$1.24M |
|
|
INOV
43
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $1.23M | 0.21% |
+75,000
| New | +$1.23M |
|
44
Axsome Therapeutics
AXSM
$6.25B
| $1.18M | 0.2% |
58,519
+50,719
| +650% | +$1.03M |
|
45
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.01M | 0.17% |
50,000
-59,196
| -54% | -$1.2M |
|
46
Natera
NTRA
$23.1B
| $984K | 0.17% |
+30,000
| New | +$984K |
|
|
ITCI
47
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $815K | 0.14% |
+109,130
| New | +$815K |
|
48
Ardelyx
ARDX
$1.57B
| $658K | 0.11% |
+140,085
| New | +$658K |
|
49
uniQure
QURE
$985M
| $590K | 0.1% |
+15,000
| New | +$590K |
|
50
Adverum Biotechnologies
ADVM
$73.9M
| $545K | 0.09% |
+10,000
| New | +$545K |
|